Preclinical restenosis models: challenges and successes.
Coronary artery disease remains a major problem for Western societies. The advent of percutaneous interventions, including stents has brought clinical care to a new level of efficacy, yet problems remain. Restenosis following stenting in human coronary arteries appears at last to be yielding to therapeutic strategies, especially drug eluting stents. Because therapeutic percutaneous coronary intervention is widely dominated by the intracoronary stent, restenosis therapies must include the stented coronary artery. Animal models and in particular the porcine coronary model seem to represent the human coronary artery reaction to stenting. It mimics several clinical conditions including thrombosis and neointimal formation. A key question in the era of intravascular technologies is how well this and other models can predict clinical events. This paper discusses the models and their application.
Touchard
Arturo G
AG
Minneapolis Heart Institute, Minneapolis, Minnesota 55407, USA.
Schwartz
Robert S
RS
D000818:Animals; D003324:Coronary Artery Disease / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D023903:Coronary Restenosis / Q000150:complications / Q000473:pathology* / Q000517:prevention & control; D003328:Coronary Thrombosis / Q000209:etiology / Q000473:pathology; D003331:Coronary Vessels / Q000293:injuries / Q000473:pathology; D004195:Disease Models, Animal; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D011817:Rabbits; D051381:Rats; D015607:Stents / Q000009:adverse effects*; D013552:Swine; D017539:Tunica Intima / Q000473:pathology